MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-15 -
MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging unique gene - MIMO Biosciences
MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-15 -
MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging unique gene - MIMO Biosciences
MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-15 -
MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging unique gene - MIMO Biosciences
MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-15 -
MIMO Biosciences offers a highly competitive salary package commensurate with qualifications and experience, along with opportunities for scientific growth within a dynamic and rapidly expanding biotechnology company. MIMO Biosciences is a biotechnology company and spin-off from the University of Na - MIMO Biosciences
MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-17 -
About MIMO MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging - MIMO Biosciences
MIMO Biosciences | Madrid, Community of Madrid, es | 2026-05-15 -
By leveraging unique genetically engineered murine systems, patient-derived xenograft (PDX) technologies, humanized mouse models, and organoid platforms, MIMO Biosciences aims to bridge the gap between preclinical discovery and clinical application. As MIMO Biosciences continues to expand, we are se - MIMO Biosciences
As MIMO Biosciences continues to expand, we are seeking talented and highly motivated scientists and postdoctoral fellows to join our multidisciplinary research team. MIMO Biosciences offers a highly competitive salary package commensurate with qualifications and experience, along with opportunities - MIMO Biosciences
MIMO Biosciences offers a highly competitive salary package commensurate with qualifications and experience, along with opportunities for scientific growth within a dynamic and rapidly expanding biotechnology company. MIMO Biosciences is a biotechnology company and spin-off from the University of Na - MIMO Biosciences
MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging unique gene - MIMO Biosciences
By leveraging unique genetically engineered murine systems, patient-derived xenograft (PDX) technologies, humanized mouse models, and organoid platforms, MIMO Biosciences aims to bridge the gap between preclinical discovery and clinical application. As MIMO Biosciences continues to expand, we are se - MIMO Biosciences
MIMO Biosciences is a biotechnology company and spin-off from the University of Navarra, founded in 2024, focused on developing advanced human-relevant experimental models to improve the prediction of drug efficacy, safety, and translational outcomes in biomedical research. By leveraging unique gene - MIMO Biosciences
